Covina, CA, Dec. 24, 2020 (GLOBE NEWSWIRE) – Psoriatic arthritis is a chronic degenerative condition associated with psoriasis. Without proper and timely treatment, the disease can lead to irreversible joint damage. Although the exact causes are not known for sure, research shows that nearly 40% of cases are due to genetic factors.
The global psoriatic arthritis market is expected to record a CAGR of 12.3% in the forecast period.
The report Global Psoriatic Arthritis Market, By Drug Class (DMARD, NSAIDs, Biologics, and others), by product type (OTC and prescription), by route of administration (Oral, Subject, and Injectable), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Bias, Analysis and Estimation to 2029 “.
Request a free copy of this Business Intelligence Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4520
Key events:
- In October, 2020, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the extended use of guselkumab (Tremfya), a monoclonal antibody (mAb) from the Janssen Johnson & Johnson Medicinal Companies.
- In October 2020, the British Association of Dermatologists updated clinical practice guidelines for biological treatment for psoriasis.
Analyst view:
Rise in frequency of psoriatic arthritis
The incidence of psoriatic arthritis is increasing every year. According to a publication by the International Journal of Clinical Rheumatology, psoriatic arthritis is estimated to be part of the spondylarthritis group, which is present in up to 42% of people with psoriasis and may account for up to 15% of spondylarthritis. patients with psoriasis on undiagnosed psoriatic arthritis. With the growing issues there is an increase in the drugs and their diagnosis and thus strengthens the psoriatic arthritis market.
Advances in chemotherapy
Over the last few years there has been progress in the personal development of drugs. This will not be able to focus on the exact location, print or area that needs to be handled. For example, Otezla is a new drug approved in 2014 for psoriatic arthritis. This drug is an oral phosphodieasterase-4 (PDE-4) inhibitor that reduces proinflammatory mediators and increases anti-inflammatory mediators.
Browse 60 market data tables * and 35 figures * through 140 slides and a deep TOC on “Global Psoriatic Arthritis Market ”, By Drug Class (DMARD, NSAIDs, Biologics, and others), by product type (OTC and prescription), by route of administration (Oral, Subject, and Injectable), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Bias, Analysis and Forecast to 2029
Request a PDF brochure @ https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/4520
Key market insights from the report:
The global psoriatic arthritis market is expected to record a CAGR of 12.3% in the forecast period. The market report has been broken down by drug class, product type, administration route and area.
- According to the drug class, DMARDs are expected to gain market control due to the first line of treatment, demand, and suitability of corticosteroids, and the major pipette-launched products, such as upadacitinib, filgotinib , and BMS-986165.
- Depending on the product type, the order segment is expected to record the highest market share and is likely to hold the lead during the forecast period. As most biologists and DMARDs sell them as prescriptions.
- In terms of route of administration, Injectables led the global psoriatic arthritis market, as a result of its anticipated launch of biology and biosimilars. Most biologists inject through the subcutaneous or intravenous pathways.
- By region, North America and Europe, both control the global psoriatic arthritis market largely as a result of commercial sales of products in the US. manufacturers, proactive government initiatives, favorable reimbursement policies, and a large patient pool support the growth of the psoriatic arthritis treatment market. Later the fastest growing market in Asia Pacific regions is expected to be due to overall economic development, development in healthcare infrastructure, increase in disposable income, and increase in consumer awareness. -use.
To know the upcoming trends and insights in this market, click on the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Psoriatic-Arthritis-Market-4520
Competitive Landscape:
Prominent players operating in the global psoriatic arthritis market include AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., AstraZeneca plc; Bausch Health Companies Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer, Inc. and UCB SA Strategic ..
The market provides detailed information on business base, productivity, strengths, manufacturers, and recent trends that help companies to expand their businesses and drive financial growth. Additionally, the report highlights dynamic features including segments, sub-segments, regional market segments, competition, key advanced players, and market forecasts. In addition, the market includes recent collaborations, unions, acquisitions, and partnerships with regulatory frameworks across different sectors that influence the market direction. Recent technological advances and innovations that have impacted the global market are included in the report.
About prophetic market ideas
Prophecy Market Insights is a specialist market research, analysis, marketing / business strategy, and solutions that provide strategic and strategic support to clients to make informed business decisions and to identify and seize high value opportunities. performance in the target area of activity. We also help our clients meet business challenges and provide the best solutions to overcome them and transform their business.
Some important points answered in this market report are given below:
- Explains an overview of the product package, including product development, design, and positioning
- Explains details of key operational strategies with a focus on R&D strategies, corporate structure, zoning strategies, production capabilities, and financial performance of different companies.
- Analysis of market revenues over the expected period.
- Exploring various market perspectives with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
- Examine the segments expected to control the market.
- A study of the expected regional survey that will record the highest growth over the expected period
Key topics covered
- Introduction
- Investigate what can be delivered
- Assumption research
- Scope of the Study
- Research Methodology
- Government Minutes
- Opportunity Map Analysis
- Prospective market
- Market share (%) and BPS analysis, by region
- Competitive Landscape
- Heat Map Analysis
- Market presence and specificity analysis
- Investment Analysis
- Competitive Analysis
Browse related reports:
- Therapeutic Market Global Rheumatoid Arthritis
To know more Contact Us: Sales Prophecy Market Insights Email- [email protected]